TEVA 629014

טבע · Healthcare - Drug Manufacturers - Specialty & Gene

12,000+1.95%agorot

Key figures - latest quarter Q2 2026 (30/06/2026) · USD

Revenue4.1B
Net income-576MMargin -13.9%
EPS-0.49
Total assets39.9B
Equity7.8B19% of assets
Cash3.7B

Financial ratios income: last 4 quarters

Valuation

Market cap140BILS
Beta0.80

Profitability

Gross margin52.5%
Operating margin18.8%
Net margin4.1%
Return on equity9.1%
Return on assets1.8%

Financial strength

Current ratio0.88
Quick ratio0.67
Liabilities / equity4.14
Equity / assets19.5%

Valuation ratios use the site's last quote.

Financial statements in millions USD, EPS in currency units

RevenueNet income
17.3B8.6B02022 · Revenue: 14,925M USD2022 · Net income: -2,446M USD20222023 · Revenue: 15,845M USD2023 · Net income: -559M USD20232024 · Revenue: 16,544M USD2024 · Net income: -1,639M USD20242025 · Revenue: 17,257M USD2025 · Net income: 1,410M USD2025
202512/2025202412/2024202312/2023202212/2022
Income statement
Revenue17,25716,54415,84514,925
Revenue growth+4.3%+4.4%+6.2%–
Gross profit8,9388,0647,6456,973
Operating income3,9523,3643,1942,690
Income before tax1,223-1,284-624-3,163
Net income1,410-1,639-559-2,446
Net margin8.2%-9.9%-3.5%-16.4%
Earnings per share1.21-1.45-0.50-2.12
Balance sheet
Cash3,5563,3003,2262,801
Current assets13,94612,55212,48512,051
Total assets40,74839,32643,47944,011
Current liabilities13,45612,79612,24711,469
Total liabilities32,83433,60635,35335,413
Shareholders' equity7,9105,3737,5067,804
Current ratio1.040.981.021.05
Debt to equity4.156.254.714.54
Cash flow
From operations1,6491,2471,3681,590
From investing737792968656
From financing-2,151-1,791-1,913-1,487

Year = the company's fiscal year. "–" = not reported. Source: SEC (US), Yahoo (Israel).

Analyst recommendations consensus target in agorot

Analyst consensusBuy

Price target (US listing, USD): 55 (Announces)

DateFirmActionRatingTargetDetails
23/09/2026OppenheimerInitiatesOutperform–Price target (US listing, USD): 50 (Announces)

Major holders

HolderPercentSharesValue (millions)Reported
Institutions
Blackrock Inc.5.48%63,894,3017,769.530/06/2026
Harel Insurance Investments &4.13%48,138,8055,853.730/06/2026
Phoenix Financial Ltd.3.68%42,933,3675,220.730/06/2026
WCM Investment Management, LLC3.55%41,315,2325,023.930/06/2026
Clal Insurance Enterprises Hol3.48%40,596,5064,936.530/06/2026
Menora Mivtachim Holdings Ltd.3.42%39,854,3834,846.330/06/2026
Migdal Insurance & Financial H3.34%38,922,2124,732.930/06/2026
NORGES BANK2.77%32,299,7533,927.630/06/2026
FMR, LLC2.60%30,258,0163,679.430/06/2026
Lingotto Investment Management1.73%20,205,9432,45730/06/2026
Funds
Vanguard Total International S1.47%17,083,5342,077.431/07/2026
WCM Focused International Grow1.14%13,253,6601,611.630/06/2026
Vanguard Developed Markets Ind0.97%11,344,3961,379.530/06/2026
New Economy Fund0.81%9,410,7951,144.430/06/2026
iShares Core MSCI EAFE ETF0.75%8,751,2201,064.131/08/2026
Fidelity International Index F0.39%4,526,975550.531/07/2026
Fidelity Rutland Square TRT II0.37%4,356,745529.831/07/2026
New World Fund Inc0.37%4,306,200523.631/07/2026
iShares MSCI EAFE ETF0.36%4,149,662504.631/08/2026
BlackRock Health Sciences Oppo0.27%3,121,339379.631/05/2026
Insiders
Elstein Amir0.18%2,118,460–05/06/2026
Francis Richard D0.10%1,177,530–05/06/2026
Barer Sol J0.04%448,011–05/06/2026
Sabag Mark0.02%224,940–17/03/2026
Hughes Eric A0.01%134,877–03/08/2026
Lieberman Gerald M0.01%130,149–05/06/2026
Crane Rosemary A0.01%127,739–05/06/2026
Nisen Perry D0.01%119,807–05/06/2026
Fox Christine0.01%75,010–04/03/2026
Mignone Roberto A.–––18/09/2026